ePrints

Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)

Lookup NU author(s): Professor Quentin AnsteeORCiD

Downloads

• Published version [.pdf]

Licence

This is the final published version of an article that has been published in its final definitive form by University of Toronto Press, 2022.

For re-use rights please refer to the publisher's terms and conditions.

Abstract

© 2022, University of Toronto Press. All rights reserved. Non-alcoholic fatty liver disease (NAFLD) affects approximately 8 million Canadians. NAFLD refers to a disease spectrum ranging from bland steatosis to non-alcoholic steatohepatitis (NASH). Nearly 25% of patients with NAFLD develop NASH, which can progress to liver cirrhosis and related end-stage complications. Type 2 diabetes and obesity represent the main risk factors for the disease. The Canadian NASH Network is a national collaborative organization of health care professionals and researchers with a primary interest in enhancing understanding, care, education, and research around NAFLD, with a vision of best practices for this disease state. At the 1st International Workshop of the CanNASH network in April 2021, a joint event with the single topic conference of the Canadian Association for the Study of the Liver (CASL), clinicians, epidemiologists, basic scientists, and community members came together to share their work under the theme of NASH. This symposium also marked the initiation of collaborations between Canadian and other key opinion leaders in the field representative of international liver associations. The main objective is to develop a policy framework that outlines specific targets, suggested activities, and evidence-based best practices to guide provincial, territorial, and federal organizations in developing multidisciplinary models of care and strategies to address this epidemic.

Publication metadata

Author(s): Sebastiani G, Patel K, Ratziu V, Feld JJ, Neuschwander-Tetri BA, Pinzani M, Petta S, Berzigotti A, Metrakos P, Shoukry N, Brunt EM, Tang A, Cobbold JF, Ekoe J-M, Seto K, Ghali P, Chevalier S, Anstee QM, Watson H, Bajaj H, Stone J, Swain MG, Ramji A

Publication type: Article

Publication status: Published

Journal: Canadian Liver Journal

Year: 2022

Volume: 5

Issue: 1

Pages: 61-90

Print publication date: 01/01/2022

Online publication date: 20/10/2021

Acceptance date: 02/04/2018

Date deposited: 23/09/2022

ISSN (electronic): 2561-4444

Publisher: University of Toronto Press

URL: https://doi.org/10.3138/canlivj-2021-0030

DOI: 10.3138/canlivj-2021-0030

Altmetrics

Funding

Share